Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History ACXP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics ACXP

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Acurx Pharmaceuticals LLC

ACXP
Current price
0.43 USD -0.043 USD (-9.00%)
Last closed 0.46 USD
ISIN US00510M1045
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 11 717 319 USD
Yield for 12 month -82.45 %
1Y
3Y
5Y
10Y
15Y
ACXP
21.11.2021 - 28.11.2021

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia; and CCP, multiple product candidates for gram-positive infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York. Address: 259 Liberty Avenue, Staten Island, NY, United States, 10305

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

5.70 USD

P/E Ratio

Dividend Yield

Financials ACXP

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures ACXP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

EBITDA
Operating Margin TTM
Price to Earnings
Return On Assets TTM -106.68 %
PEG Ratio
Return On Equity TTM -285.79 %
Wall Street Target Price 5.70 USD
Revenue TTM
Book Value 0.10 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.70 USD
Diluted Eps TTM -0.70 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation ACXP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -3.54
Price Book MRQ 5.08

Technical Indicators ACXP

For 52 Weeks

0.30 USD 3.33 USD
50 Day MA 0.43 USD
Shares Short Prior Month 527 341
200 Day MA 0.89 USD
Short Ratio 2.24
Shares Short 657 629
Short Percent 2.53 %